Ads
related to: lunesta alternative- FAQs
Have a Question?
Get Answers
- Demonstrated Safety
Safety Was Evaluated In Adults
With Insomnia. Know More.
- Efficacy Data
Read Our
Clinical Trial Data
- Safety Information
Get Details on Our
Safety Profile
- FAQs
Search results
Results From The WOW.Com Content Network
The tables below contain a sample list of benzodiazepines and benzodiazepine analogs that are commonly prescribed, with their basic pharmacological characteristics, such as half-life and equivalent doses to other benzodiazepines, also listed, along with their trade names and primary uses.
Eszopiclone, sold under the brand name Lunesta among others, is a medication used in the treatment of insomnia. [ 3 ] [ 4 ] Evidence supports slight to moderate benefit up to six months. [ 5 ] [ 4 ] [ 6 ] It is taken by mouth .
[76] [77] In 2005, the pharmaceutical company Sepracor of Marlborough, Massachusetts, began marketing the active stereoisomer eszopiclone under the name Lunesta in the United States. This had the consequence of placing what is a generic drug in most of the world under patent control in the United States. Generic forms of Lunesta have since ...
“Short track record means that new, unexpected side effects are possible,” it explains. “Since this drug has a different way of acting than other insomnia drugs, the experience with it is particularly limited.” The label gives brief details on alternative remedies for insomnia, like cutting down on caffeine.
Chemical structure of the prototypical Z-drug zolpidem. Nonbenzodiazepines (/ ˌ n ɒ n ˌ b ɛ n z oʊ d aɪ ˈ æ z ɪ p iː n,-ˈ eɪ-/ [1] [2]), sometimes referred to colloquially as Z-drugs (as many of their names begin with the letter "z"), are a class of psychoactive, depressant, sedative, hypnotic, anxiolytic drugs that are benzodiazepine-like in uses, such as for treating insomnia [3 ...
On July 1, 2023, Sunovion Pharmaceuticals Inc. became part of Sumitomo Pharma America, Inc., [1] a biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry and neurology, oncology, urology, women's health, rare disease, and cell and gene therapies.
Ad
related to: lunesta alternative